Systemic corticosteroids show no benefit in severe and critical COVID-19
patients in Wuhan, China: A retrospective cohort study

https://doi.org/10.1101/2020.05.11.20097709

In a retrospective cohort study in Wuhan, corticosteroids were administered in 531 (35.1%) severe and 159 (63.9%)
critical patients. Compared to no corticosteroid use group, systemic corticosteroid use showed no benefit in reducing in-hospital mortality in both severe cases and critical cases.